Incidence and Outcomes Associated With Early Heart Failure Pharmacotherapy in Patients with Ongoing Cardiogenic Shock
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11120%2F14%3A43908087" target="_blank" >RIV/00216208:11120/14:43908087 - isvavai.cz</a>
Result on the web
<a href="http://dx.doi.org/10.1097/CCM.0b013e31829f6242" target="_blank" >http://dx.doi.org/10.1097/CCM.0b013e31829f6242</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1097/CCM.0b013e31829f6242" target="_blank" >10.1097/CCM.0b013e31829f6242</a>
Alternative languages
Result language
angličtina
Original language name
Incidence and Outcomes Associated With Early Heart Failure Pharmacotherapy in Patients with Ongoing Cardiogenic Shock
Original language description
Guidelines recommend beta-blockers and renin-angiotensin-aldosterone system blockers to improve long-term survival in hemodynamically stable myocardial infarction patients with a reduced left ventricular ejection fraction. The prevalence and outcomes associated with beta and renin-angiotensin-aldosterone system blocker therapy in patients with ongoing cardiogenic shock is unknown. In patients with cardiogenic shock lasting more than 24 hours enrolled in Tilarginine Acetate Injection in a Randomized International Study in Unstable Myocardial Infarction Patients With Cardiogenic Shock, we compared 30-day mortality in patients who received beta or renin-angiotensin-aldosterone system blockers within 24 hours of randomization with those who did not. The final study population included 240 patients. A total of 66 patients (27.5%) had either beta blocker or renin-angiotensin-aldosterone system blocker administered within the first 24 hours after the diagnosis of cardiogenic shock. Beta block
Czech name
—
Czech description
—
Classification
Type
J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)
CEP classification
FA - Cardiovascular diseases including cardio-surgery
OECD FORD branch
—
Result continuities
Project
—
Continuities
N - Vyzkumna aktivita podporovana z neverejnych zdroju
Others
Publication year
2014
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Critical Care Medicine
ISSN
0090-3493
e-ISSN
—
Volume of the periodical
42
Issue of the periodical within the volume
2
Country of publishing house
US - UNITED STATES
Number of pages
8
Pages from-to
281-288
UT code for WoS article
000329863400023
EID of the result in the Scopus database
—